etoposide has been researched along with vanadates in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biersack, H; Boege, F; Clark, M; Gieseler, F | 1 |
| Biersack, H; Boege, F; Meyer, P | 1 |
| Biersack, H; Boege, F; Gieseler, F; Meyer, P | 1 |
| Frey, T; Ledbetter, JA; Lund-Johansen, F; Thompson, PA | 1 |
| Lazo, JS; Rice, RL; Woo, ES | 1 |
| Cruz, M; Eneroth, P; Sidén, A; Vargas, VI; Yakisich, JS | 1 |
| Amachi, T; Kioka, N; Matsuo, M; Nagata, K; Nishitani, M; Ueda, K | 1 |
| Aizu-Yokota, E; Hasegawa, M; Kasahara, T; Momoi, T; Sakurai, S; Sonoda, Y; Yamamoto, D | 1 |
| Elliott, T; Haslett, C; Hodkinson, PS; Mackinnon, AC; Rintoul, RC; Sethi, T; Wong, WS | 1 |
| Atarashi, Y; Sato, TA; Stanson, J; Whiteside, TL; Wieckowski, E | 1 |
10 other study(ies) available for etoposide and vanadates
| Article | Year |
|---|---|
Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment.
Topics: Amsacrine; Catalysis; Cell Line; Chromatography, Ion Exchange; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; Protein Conformation; Structure-Activity Relationship; Vanadates | 1991 |
Drug-sensitivity and DNA-binding of a subform of topoisomerase II alpha in resistant human HL-60 cells.
Topics: Amsacrine; Antigens, Neoplasm; Antineoplastic Agents; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Drug Resistance; Etoposide; Humans; Isoenzymes; Leukemia; Tumor Cells, Cultured; Vanadates | 1994 |
Different functional states of topoisomerase II can be discriminated by orthovanadate sensitivity in multi-drug resistant human leukemic cells.
Topics: Adenosine Triphosphate; Allosteric Site; Amsacrine; Chromatography, Ion Exchange; Clone Cells; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; Isoenzymes; Leukemia, Promyelocytic, Acute; Molecular Weight; Neoplasm Proteins; Neoplastic Stem Cells; Point Mutation; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vanadates | 1993 |
Apoptosis in hematopoietic cells is associated with an extensive decrease in cellular phosphotyrosine content that can be inhibited by the tyrosine phosphatase antagonist pervanadate.
Topics: Animals; Apoptosis; Blood Cells; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Flow Cytometry; Hematopoiesis; Humans; In Vitro Techniques; Mice; Phosphotyrosine; Protein Tyrosine Phosphatases; Thymus Gland; Tumor Cells, Cultured; Vanadates | 1996 |
Cell cycle dependent subcellular distribution of Cdc25B subtypes.
Topics: Animals; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; CHO Cells; Cricetinae; DNA Damage; Enzyme Inhibitors; Etoposide; Green Fluorescent Proteins; Luminescent Proteins; Microscopy, Video; Phenotype; Phosphoprotein Phosphatases; Phosphorylation; Recombinant Fusion Proteins; Subcellular Fractions; Transfection; Vanadates | 1999 |
Early effects of protein kinase modulators on DNA synthesis in rat cerebral cortex.
Topics: Animals; Anti-Inflammatory Agents; Benzoquinones; Camptothecin; Cerebral Cortex; Dimethyl Sulfoxide; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Genistein; Lactams, Macrocyclic; Naphthalenes; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Sprague-Dawley; Rifabutin; Staurosporine; Steroids; Vanadates | 1999 |
Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1.
Topics: Adenosine Triphosphate; ATP-Binding Cassette Transporters; Azides; Binding Sites; Cell Membrane; Drug Resistance, Multiple; Etoposide; Glutathione; Glutathione Disulfide; Humans; KB Cells; Kinetics; Multidrug Resistance-Associated Proteins; Protein Folding; Recombinant Proteins; Transfection; Trypsin; Vanadates | 2000 |
FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 6; Caspases; Cell Death; Cell Survival; Cysteine Proteinase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Etoposide; Fingolimod Hydrochloride; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; Immunosuppressive Agents; Oligopeptides; Phosphatidylinositol 3-Kinases; Phosphorylation; Propylene Glycols; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sphingosine; Time Factors; Tumor Cells, Cultured; Tyrosine; Vanadates | 2001 |
ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Small Cell; Cell Adhesion; Cell Cycle; Cell Line, Tumor; DNA Damage; Etoposide; Extracellular Matrix; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Integrin beta1; Laminin; Lung Neoplasms; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Vanadates | 2006 |
FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Topics: Antibodies; Apoptosis; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Survival; Cyclohexylamines; Etoposide; fas Receptor; Head and Neck Neoplasms; Humans; NF-kappa B; Protein Phosphatase 1; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Signal Transduction; Staurosporine; Up-Regulation; Vanadates | 2007 |